The isolated prolonged PTT

Oxana Tcherniantchouk, Michael Laposata, Marisa B. Marques

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

It is increasingly difficult to choose the proper tests to investigate an abnormal laboratory result, delaying the time to reach the correct diagnosis and increasing the cost of care. A wrong choice may also lead to clinically significant errors, which can be life threatening. To show how errors in test selection occur in routine medical practice, the authors describe an algorithm to evaluate patients with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time. This exercise challenges the commonly held belief that errors in laboratory utilization occur primarily with esoteric and/or genetic testing, rather than in patients with common abnormalities such as a prolonged PTT.

Original languageEnglish (US)
Pages (from-to)82-85
Number of pages4
JournalAmerican Journal of Hematology
Volume88
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Partial Thromboplastin Time
Prothrombin Time
Genetic Testing
Exercise
Costs and Cost Analysis

ASJC Scopus subject areas

  • Hematology

Cite this

The isolated prolonged PTT. / Tcherniantchouk, Oxana; Laposata, Michael; Marques, Marisa B.

In: American Journal of Hematology, Vol. 88, No. 1, 01.2013, p. 82-85.

Research output: Contribution to journalArticle

Tcherniantchouk, O, Laposata, M & Marques, MB 2013, 'The isolated prolonged PTT', American Journal of Hematology, vol. 88, no. 1, pp. 82-85. https://doi.org/10.1002/ajh.23285
Tcherniantchouk, Oxana ; Laposata, Michael ; Marques, Marisa B. / The isolated prolonged PTT. In: American Journal of Hematology. 2013 ; Vol. 88, No. 1. pp. 82-85.
@article{4477f99767ad485ab5c0b64f2577f299,
title = "The isolated prolonged PTT",
abstract = "It is increasingly difficult to choose the proper tests to investigate an abnormal laboratory result, delaying the time to reach the correct diagnosis and increasing the cost of care. A wrong choice may also lead to clinically significant errors, which can be life threatening. To show how errors in test selection occur in routine medical practice, the authors describe an algorithm to evaluate patients with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time. This exercise challenges the commonly held belief that errors in laboratory utilization occur primarily with esoteric and/or genetic testing, rather than in patients with common abnormalities such as a prolonged PTT.",
author = "Oxana Tcherniantchouk and Michael Laposata and Marques, {Marisa B.}",
year = "2013",
month = "1",
doi = "10.1002/ajh.23285",
language = "English (US)",
volume = "88",
pages = "82--85",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - The isolated prolonged PTT

AU - Tcherniantchouk, Oxana

AU - Laposata, Michael

AU - Marques, Marisa B.

PY - 2013/1

Y1 - 2013/1

N2 - It is increasingly difficult to choose the proper tests to investigate an abnormal laboratory result, delaying the time to reach the correct diagnosis and increasing the cost of care. A wrong choice may also lead to clinically significant errors, which can be life threatening. To show how errors in test selection occur in routine medical practice, the authors describe an algorithm to evaluate patients with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time. This exercise challenges the commonly held belief that errors in laboratory utilization occur primarily with esoteric and/or genetic testing, rather than in patients with common abnormalities such as a prolonged PTT.

AB - It is increasingly difficult to choose the proper tests to investigate an abnormal laboratory result, delaying the time to reach the correct diagnosis and increasing the cost of care. A wrong choice may also lead to clinically significant errors, which can be life threatening. To show how errors in test selection occur in routine medical practice, the authors describe an algorithm to evaluate patients with a prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time. This exercise challenges the commonly held belief that errors in laboratory utilization occur primarily with esoteric and/or genetic testing, rather than in patients with common abnormalities such as a prolonged PTT.

UR - http://www.scopus.com/inward/record.url?scp=84871421741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871421741&partnerID=8YFLogxK

U2 - 10.1002/ajh.23285

DO - 10.1002/ajh.23285

M3 - Article

VL - 88

SP - 82

EP - 85

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -